Antigen-functionalized turnip mosaic virus nanoparticles increase antibody sensing in saliva. A case study with SARS-CoV-2 RBD.

Antigen-functionalized turnip mosaic virus nanoparticles increase antibody sensing in saliva. A case study with SARS-CoV-2 RBD.

Publication date: Jul 01, 2024

Nanoparticles derived from plant viruses play an important role in nanomedicine due to their biocompatibility, self-assembly and easily-modifiable surface. In this study, we developed a novel platform for increasing antibody sensing using viral nanoparticles derived from turnip mosaic virus (TuMV) functionalized with SARS-CoV-2 receptor binding domain (RBD) through three different methods: chemical conjugation, gene fusion and the SpyTag/SpyCatcher technology. Even though gene fusion turned out to be unsuccessful, the other two constructs were proven to significantly increase antibody sensing when tested with saliva of patients with different infection and vaccination status to SARS-CoV-2. Our findings show the high potential of TuMV nanoparticles in the fields of diagnostics and immunodetection, being especially attractive for the development of novel antibody sensing devices.

Concepts Keywords
Biocompatibility Antibodies, Viral
Spytag Antibodies, Viral
Turnip Antibody sensing
Vaccination Antigens, Viral
Viruses Antigens, Viral
COVID-19
Humans
Nanoparticles
Saliva
Saliva;IgA
SARS-CoV-2
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
Turnip mosaic virus
Tymovirus
VLP

Semantics

Type Source Name
disease VO Viruses
disease VO gene
disease MESH infection
disease VO vaccination
disease MESH COVID-19
disease VO Glycoprotein

Original Article

(Visited 1 times, 1 visits today)